“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Paul B. Renz, DO, discussed the ideal uses of MR-LINAC in pancreatic, prostate, liver, head and neck, and rectal cancers.

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Dr. Ranjit S. Bindra discusses recent advancements for the treatment of patients with primary brain tumors during Brain ...

Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with ...

Oncosil Medical Ltd.’s brachytherapy device outperformed stereotactic body radiation therapy plus chemotherapy in patients with unresectable or borderline-resectable locally advanced pancreatic cancer ...

Announcing a new publication for Acta Materia Medica journal. A preclinical study has developed a precision nano-intervention ...